GLUT1 regulates cell glycolysis and proliferation in prostate cancer

Glucose transporter 1 (GLUT1) plays a critical role in tumorigenesis and tumor progression in multiple cancer types. However, the specific function and clinical significance of GLUT1 in prostate cancer (PCa) are still unclear. Therefore, in this study, we investigated the role of GLUT1 in PCa.

[1]  Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells , 2017, Asian Pacific journal of cancer prevention : APJCP.

[2]  Jörg Marienhagen,et al.  GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. , 2009, The American journal of pathology.

[3]  I. Shin,et al.  Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells , 2017, BMB reports.

[4]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[5]  N. Avril,et al.  Molecular positron emission tomography and PET/CT imaging in urological malignancies. , 2007, European urology.

[6]  Bing Zhang,et al.  MicroRNA-124 suppresses proliferation and glycolysis in non–small cell lung cancer cells by targeting AKT–GLUT1/HKII , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[7]  K. Kalland,et al.  Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes , 2016, BMC Cancer.

[8]  Yu Zhou,et al.  The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis , 2017, Oncotarget.

[9]  Chao Xu,et al.  Crystal structure of the human glucose transporter GLUT1 , 2014, Nature.

[10]  Gavin Kelly,et al.  Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. , 2012, Cancer discovery.

[11]  P. Sutphin,et al.  Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality , 2011, Science Translational Medicine.

[12]  M. Alves,et al.  Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes , 2015, Journal of Cancer Research and Clinical Oncology.

[13]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[14]  R. J. Gooding,et al.  Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes , 2016, Cancer & metabolism.

[15]  T. Peters,et al.  Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. , 2014, The Lancet. Oncology.

[16]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[17]  T. Wilt,et al.  Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer , 2017, The New England journal of medicine.

[18]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[19]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[20]  M. Alves,et al.  Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile. , 2012, The international journal of biochemistry & cell biology.

[21]  E. Williams,et al.  Expression and localization of GLUT1 and GLUT12 in prostate carcinoma , 2003, Cancer.

[22]  Roeland M. H. Merks,et al.  Glycolytic regulation of cell rearrangement in angiogenesis , 2016, Nature Communications.

[23]  Anneleen Daemen,et al.  mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. , 2016, Cancer cell.

[24]  Richard A. Roth,et al.  Regulation of GLUT1 Gene Transcription by the Serine/Threonine Kinase Akt1* , 1999, The Journal of Biological Chemistry.

[25]  W. Muller,et al.  The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis , 2016, Breast Cancer Research.

[26]  B. Ebert,et al.  Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*) , 1995, The Journal of Biological Chemistry.

[27]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[28]  J. Mayo,et al.  Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells. , 2014, Endocrinology.

[29]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[30]  A. Godoy,et al.  Cellular distribution of Glut‐1 and Glut‐5 in benign and malignant human prostate tissue , 2012, Journal of cellular biochemistry.